VanEck Associates
BCPC

VanEck Associates’s Balchem Corp BCPC Stock Holding History

VanEck Associates’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Sell
3,520
-110
-3% -$18.7K ﹤0.01% 1156
2025
Q4 		$556K Sell
3,630
-24,008
-87% -$3.66M ﹤0.01% 1163
2025
Q3 		$4.15M Buy
27,638
+1,340
+5% +$211K ﹤0.01% 821
2025
Q2 		$4.19M Sell
26,298
-2,899
-10% -$470K ﹤0.01% 784
2025
Q1 		$4.85M Sell
29,197
-38,165
-57% -$6.26M 0.01% 725
2024
Q4 		$11M Buy
67,362
+3,110
+5% +$540K 0.01% 442
2024
Q3 		$10.7M Sell
64,252
-577
-0.9% -$98.3K 0.01% 431
2024
Q2 		$9.98M Buy
64,829
+485
+0.8% +$73K 0.01% 416
2024
Q1 		$9.97M Sell
64,344
-1,553
-2% -$230K 0.02% 403
2023
Q4 		$9.8M Sell
65,897
-5,567
-8% -$712K 0.02% 377
2023
Q3 		$8.87M Sell
71,464
-270
-0.4% -$35.9K 0.02% 361
2023
Q2 		$9.67M Sell
71,734
-4,301
-6% -$553K 0.02% 360
2023
Q1 		$9.62M Buy
76,035
+137
+0.2% +$17.7K 0.02% 360
2022
Q4 		$9.27M Sell
75,898
-3,679
-5% -$486K 0.02% 347
2022
Q3 		$9.68M Sell
79,577
-8,405
-10% -$1.09M 0.03% 317
2022
Q2 		$11.4M Buy
87,982
+24,817
+39% +$3.11M 0.03% 312
2022
Q1 		$8.63M Buy
63,165
+9,436
+18% +$1.35M 0.02% 392
2021
Q4 		$9.06M Sell
53,729
-2,221
-4% -$356K 0.02% 392
2021
Q3 		$8.12M Sell
55,950
-3,924
-7% -$531K 0.02% 378
2021
Q2 		$7.86M Buy
59,874
+872
+1% +$112K 0.02% 380
2021
Q1 		$7.4M Buy
59,002
+15,035
+34% +$1.83M 0.02% 382
2020
Q4 		$5.07M Buy
43,967
+6,575
+18% +$694K 0.01% 379
2020
Q3 		$3.65M Buy
37,392
+1,938
+5% +$190K 0.01% 378
2020
Q2 		$3.36M Sell
35,454
-2,309
-6% -$216K 0.01% 391
2020
Q1 		$3.73M Sell
37,763
-2,798
-7% -$287K 0.02% 370
2019
Q4 		$4.12M Sell
40,561
-1,598
-4% -$161K 0.02% 395
2019
Q3 		$4.18M Buy
42,159
+943
+2% +$89.9K 0.02% 362
2019
Q2 		$4.12M Sell
41,216
-12,099
-23% -$1.18M 0.02% 369
2019
Q1 		$4.95M Sell
53,315
-4,281
-7% -$369K 0.02% 306
2018
Q4 		$4.51M Sell
57,596
-1,184
-2% -$107K 0.02% 320
2018
Q3 		$6.59M Sell
58,780
-3,903
-6% -$410K 0.03% 285
2018
Q2 		$6.15M Buy
62,683
+2,487
+4% +$232K 0.03% 277
2018
Q1 		$4.92M Buy
60,196
+8,150
+16% +$642K 0.02% 294
2017
Q4 		$4.2M Buy
52,046
+854
+2% +$71.1K 0.02% 303
2017
Q3 		$4.16M Sell
51,192
-5,097
-9% -$391K 0.02% 312
2017
Q2 		$4.37M Buy
56,289
+2,990
+6% +$238K 0.02% 297
2017
Q1 		$4.39M Sell
53,299
-1,596
-3% -$134K 0.02% 309
2016
Q4 		$4.61M Sell
54,895
-8,073
-13% -$637K 0.02% 306
2016
Q3 		$4.88M Buy
62,968
+295
+0.5% +$19.6K 0.02% 285
2016
Q2 		$3.74M Buy
62,673
+4,131
+7% +$253K 0.02% 308
2016
Q1 		$3.63M Sell
58,542
-5,683
-9% -$341K 0.02% 270
2015
Q4 		$3.9M Sell
64,225
-9,350
-13% -$607K 0.03% 250
2015
Q3 		$4.47M Sell
73,575
-19,898
-21% -$1.15M 0.03% 246
2015
Q2 		$5.21M Sell
93,473
-853
-0.9% -$49.1K 0.03% 262
2015
Q1 		$5.22M Sell
94,326
-5,278
-5% -$302K 0.03% 264
2014
Q4 		$6.64M Buy
+99,604
New +$6.22M 0.04% 225

Other funds holding BCPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates's BCPC Position: Q1 2026 in Review

VanEck Associates reduced its Balchem Corp (BCPC) stake by 3% in Q1 2026, selling an estimated $18.7K and leaving 3,520 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

VanEck Associates first reported a position in BCPC in Q4 2014 and has held it in 46 quarters since. The position peaked at $11.4M in Q2 2022. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • VanEck Associates held 3,520 shares of Balchem Corp worth $596K as of Q1 2026.
  • VanEck Associates sold 110 Balchem Corp shares in Q1 2026, an estimated $18.7K.
  • Balchem Corp made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1156 holding.
  • VanEck Associates first reported a position in Balchem Corp in Q4 2014 and has held it in 46 quarters since.
  • VanEck Associates's Balchem Corp position peaked at $11.4M in Q2 2022.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.